The Morbidly Obese Patient in the Critical Care Unit


Morbidly obese patients have significant anatomic and pathophysiologic changes of the pulmonary system. Reduced lung volumes, increased work of breathing, respiratory muscle inefficiency, and alterations in control of breathing and gas exchange can complicate the care of the morbidly obese. Many factors are involved including, but not limited to, BMI, patient’s age, duration of obesity, fat distribution (central or peripheral), and the strong association of certain sleep-related breathing disorders such as obstructive sleep apnea (OSA) and obesity hypoventilation syndrome (OHS) (16).

Morbidly obese patients have the lower functional residual capacity (FRC), expiratory reserve volume (ERV) and to a lesser extent total lung capacity (TLC). Forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and maximum voluntary ventilation (MVV) are also reduced in the morbidly obese suggesting small airway remodeling and decrease in caliber. These changes are worsened by supine positioning, in which diaphragmatic movement is hampered by the increased abdominal pressure. The increased adipose tissue around the rib cage decreases chest wall compliance, which also reduces FRC. As the FRC decreases it approaches the closing capacity, which can lead to airway closure within the range of tidal breathing. Areas of the lung may be underventilated leading to intrapulmonary shunting and hypoxemia. Respiration can also be comprised by early airway closure resulting in air trapping and auto-PEEP, which increases work of breathing (17). This loss of FRC with resultant smaller airway collapse and atelectasis decreases pulmonary compliance. Increased blood volume within the pulmonary circulation also contributes to the diminished pulmonary compliance and is exponentially related to BMI. These changes result in increased work of breathing, which is compounded by decreased diameter of the upper airway caused by parapharangeal fat (18).

As with nonobese individuals, lower lung segments in the obese are well perfused, but because of the closure of small airways in these areas, ventilation is shifted to the upper lung segments resulting in increased V/Q mismatch and hypoxemia. Chronic hypoxemia contributes to persistent increased pulmonary vascular resistance and right heart failure. The level of hypoxemia is worse in OHS. Respiratory muscle endurance is also decreased in the obese patient and to a greater degree in OHS with a marked increase in oxygen consumption of the respiratory muscles. This decline in respiratory muscle endurance leads to earlier fatigue and respiratory failure (18).

Obese patients require higher minute ventilation to match the oxygen consumption and metabolic demands, which result in increased respiratory rate and shallower volumes. In OHS, the neural drive fails resulting in hypercapnia and hypoxia. There is not a linear association between these respiratory changes and degree of obesity. However, the cumulative effect can result in lower pulmonary reserve and increase the risk of respiratory failure in obese patients (17).

Obstructive sleep apnea syndrome (OSAS) is more prevalent in the morbidly obese than OHS and is often underdiagnosed. This can lead to difficulties in the management of morbidly obese patients in stressed situations such as perioperative or in acute disease states where OSAS pathophysiology may not be recognized. OSAS is associated with increased risk of postoperative cardiac events, respiratory failure, and intensive care admissions. OSAS is associated with difficult mask ventilation and intubation. OSAS patients are more susceptible to sedation effect of hypnotics and opioids. OSAS is also associated with increased overall mortality (19). Use of empiric positive airway pressure in patients who are high risk for OSA but undiagnosed may be of use in the management of the morbidly obese for perioperative care, acute respiratory failure, and bridge after extubation (20–22). In patients with OHS, noninvasive continuous positive airway pressure may improve upper airway patency, increase FRC, offset auto-PEEP, augment respiratory muscles, and oxygenation. However, the additional inspiratory component of bilevel positive airway pressure helps ameliorate the hypercapnia of OHS. Noninvasive positive pressure ventilation (NIPPV) does not appear to impact the need for endotracheal intubation in acute hypoxic respiratory failure due to ARDS in this population, however so close monitoring of these patients is warranted preferably in an intensive care setting where difficult airways can be managed if intubation is warranted (16).

It is still a debatable issue whether or not morbid obesity should be considered a risk factor for difficult airway management especially in the elective situation such as in the operating room. More important was consideration of Mallampati score of 3 or greater, previous documented difficult airway, limited mouth opening or cervical mobility, and history of OSA. There is also some data to suggest that patients intubated in the intensive care unit are more likely to have difficult airways and complications related to intubation than those patients in an operating room setting (23). Whether or not morbid obesity is considered a risk factor for intubation, issues related specifically to the patient’s BMI that impact airway management should be considered.

Less cardiopulmonary reserve in the morbidly obese from pathophysiologic changes described previously results in more rapid desaturation during intubation. Supine positioning increases V/Q mismatch thereby worsening hypoxemia. Obesity alters upper airway anatomy. Increased fat deposition in pharyngeal tissues increases the likelihood of pharyngeal wall collapse and also decreases the cross-sectional area of the upper trachea. These changes, as well as increased airway resistance from decreased pulmonary and chest wall compliance, makes bag mask ventilation more difficult. Obese patients have increased the risk of aspiration pneumonitis resulting from increased intra-abdominal pressure (IAP) and increase in gastric volumes (23).

The key to maximizing intubation success and decreasing complications is preparation if possible with the following important points preoxygenation, positioning, and resources. Preoxygenation with 100% oxygen by mask or by NIPPV with the patient in the 30- to 45-degree head up or reverse Trendelenburg position. This positioning helps unload the abdominal contents from the diaphragm. Before induction of sedation, the obese patient should be placed in a ramped position. In the ramped position, blankets or commercially available tools or beds are used to elevate the head and torso such that the external auditory meatus and the sternum are horizontally aligned. Essential equipment and personnel should be gathered. The exact list of equipment needed may vary slightly depending on the intubating individual’s preference, but endotracheal tubes with stylets, functioning suction, a bag-valve device connected to an oxygen source, laryngoscope (direct or video) and blades, oral/nasal airways, and a device to detect end-tidal carbon dioxide are essential. Continued oxygen delivery via high-flow nasal cannula during laryngoscopy may extend safe apnea time. All providers who are responsible for intubation of critically ill morbidly obese should be familiar with an accepted difficult airway guideline (Table 69.2) (24–27).

Obesity is associated with more severe asthma and increased risk of adult respiratory distress syndrome (ARDS). Recent viral pandemics such as H1N1 showed obesity as a risk factor for ARDS and multi-system organ failure. However, BMI alone is not associated with increased mortality from ARDS (28). Morbidly obese patients often require longer ventilatory support in their normal weight counterpart. The mechanically ventilated morbidly obese patient presents the critical care physician with unique challenges. There is no clear optimum mode of ventilation in the critically ill, mechanically ventilated morbidly obese patient. Much of the literature on ventilation in this population is from elective surgical patients undergoing bariatric surgery. Positioning the patient in a 70-degree sitting position rather than a semi-Fowler position where the head of the bed is at 30 to 45 degrees has been reported to improve expiratory flow and decrease auto-PEEP (29). Recent studies suggest that intensivists underestimate appropriate PEEP needed to optimize end-expiratory lung volumes in the intubated morbidly obese patient. Utilization of pressure–volume curve to determine lower inflection point (where alveoli collapse) or utilization of esophageal balloon manometry as a surrogate for transpleural pressure may be a better guide to determining the optimal level of PEEP in these patients. Some authors suggest routine recruitment maneuvers shortly after intubation (i.e., PEEP 30 cm H2O for 30 seconds) in addition to PEEP guided by transpleural pressure monitoring or equivalent (30). If estimating, empiric PEEP of 10 to 15 cm H2O has been suggested as optimal for the morbidly obese mechanically ventilated patient (31). Ideal body weight should be used to determine tidal volume and monitoring of acid–base status as a guide to appropriate minute ventilation.

TABLE 69.2 Summary of Endotracheal Intubation Concerns in Morbidly Obese Patients

TABLE 69.3 Vital Measures to Prevent or Reduce the Severity and Duration of Atelectasis in the Obese Patient

When preparing to extubate the morbidly obese patient, one must take into consideration the underlying lung mechanics. Decreasing PEEP to 5 cm H2O or use of T-piece during weaning may result in loss of recruited end-expiratory volume. Keeping PEEP above the level of lower inflection point during weaning may prevent derecruitment. Postextubation bridging with NIPPV at the same level of PEEP used during weaning should be considered. NIPPV helps overcome upper airway resistance, decreases respiratory muscle fatigue and prevents atelectasis (32). Keeping the patient in a more upright position will also help optimize lung mechanics (Table 69.3).


It is vital to maintain the best possible ventilation/perfusion (V/Q) balance because V/Q mismatch is a prominent mechanism that can trigger respiratory and subsequent cardiac dysfunction in the morbidly obese patient. In mechanically ventilated, morbidly obese patients, airway pressure may be elevated. Additionally, morbid obesity is associated with volume and pressure overload. Volume load conditions may fluctuate according to patient positioning. For example, changing position from the “physiologically ideal” reverse Trendelenburg to the supine position can significantly increase venous blood return to the heart and, as a result, augment cardiac output, pulmonary capillary wedge pressure, and mean pulmonary artery pressure, potentially increasing the risk of acute heart failure; one would expect this maneuver to increase airway pressure as well due to the increased weight of the chest.

Compression of the inferior vena cava may reduce venous return to the heart, and is thus a possible mechanism of hypotension. This can be avoided by placing a wedge under the patient. Considering that the reverse Trendelenburg position or semi-Fowler position significantly improves cardiac and respiratory performance, it should be maintained unless there is a particular contraindication (33).


Morbid obesity is a risk factor for chronic kidney disease (CKD). Comorbidities such as hypertension and diabetes contribute to decrease in kidney function as well as the increased glomerular filtration rate (GFR) from morbid obesity itself. Obesity-related glomerulopathy is manifested as glomerulomegaly, mesangial expansion, and secondary focal and segmental glomerulosclerosis. CKD is a risk factor for acute kidney injury (AKI). The critically ill morbidly obese patient increased GFR might mask underlying renal insufficiency predisposing these patients to AKI from inappropriate drug dosing, exposure to nephrotoxins such as IV contrast dye, overestimation of intravascular volume, and failure to recognize abdominal compartment syndrome (ACS) (34).

AKI increases mortality in the critically morbidly obese patient. Strategies to avoid AKI in the critically ill morbidly obese patient include recognition of the risk of underlying kidney pathology. Class III obesity and above have been shown to be an independent risk factor in developing AKI in the perioperative population. Obtaining euvolemia while maintaining renal perfusion pressure with minimum vasopressors is a logical goal. Management of dynamic fluid responsiveness should avoid suspected nephrotoxins, such as starch based colloids (35).


There is an increased prevalence of gastroesophageal reflux in the morbidly obese. Coupled with increased gastric volume, increased IAP and decreased lower esophageal sphincter, the obese patient is at risk for aspiration during critical illness and endotracheal intubation. Several studies have shown an association between increases in BMI and intra-abdominal hypertension (defined as IAP >12 mmHg). This baseline increase in IAP can predispose obese individuals to develop ACS. ACS occurs when the IAP exceeds 20 mmHg with evidence of organ dysfunction, such as oliguria, decreased cardiac output from impedance on venous return, decreased pulmonary compliance, increased intracranial pressure, and lactic acidosis. Disorders such as ascites, intra-abdominal hemorrhage, visceral edema, bowel distension, or large abdominal tumors can lead to ACS. Treatment is usually focused on the cause (i.e., paracentesis for massive ascites) and sometimes may require surgical decompression.

Nonalcoholic fatty liver disease (NAFLD) is more prevalent in the obese patient. The NAFLD covers a spectrum of disease, from asymptomatic elevations of alanine transaminase to steatosis with lobular inflammation and ballooning degeneration, termed nonalcoholic steatohepatitis (NASH) to liver fibrosis and cirrhosis. Some patients diagnosed with NAFLD may have NASH or cirrhosis, which could lead to complications, particularly prolonged drug metabolism and relative immune suppression of liver disease, and worse outcomes in the intensive care unit (36).


The distribution, metabolism, protein binding, and clearance of many drugs are altered by the physiologic changes associated with obesity as reviewed in the previous sections. Also, obesity-associated comorbidities may substantially influence the pharmacokinetic properties of a drug. Although data on effects of morbid obesity on pharmacokinetics is increasing, there is still a paucity of well-powered studies. This clinician should be aware of weight-based dosing is complicated by which value one uses: ideal body weight, adjusted body weight, or actual body weight. Many drugs used in the intensive care setting can be titrated to obvious effect such as vasoactive medications. Although sedation and pain medications can also be titrated to effect, the lipophilic nature of commonly used benzodiazepines may prolong elimination of these drugs. Sedation and opiates in the nonintubated seriously ill morbidly obese patient requires heightened awareness as this population may have undiagnosed sleep-disordered breathing and may have increased hypercapnia and hypoxia (37). Some drugs can be monitored in steady state by drug levels or laboratory values. However, often it is imperative to have adequate initial or loading dosing for many drugs in the critically ill. For example, underdosing antimicrobials by providers has been shown to be common in the morbidly obese which may lead to treatment failure and resistance (38). Drugs with narrow therapeutic windows such as anticoagulants should be monitored closely. Consultation with critical care pharmacists and development of protocols can help achieve early adequate dosing (39).


Obesity is a risk factor for venous thromboembolic disease. Literature suggests relative risk for deep vein thrombosis (DVT) of 2.50 in obese versus nonobese patients and relative risk for pulmonary embolus (PE) of 2.21 (40).

There are several proposed mechanisms for the increased risk of VTE in obese patients in the intensive care unit. Because of limitations of body habitus, these patients are often less ambulatory and assisted mobilization in the hospital may also be limited. Also, prophylactic measures may be inadequate. Compression devices are less likely to fit properly, and the limited data on appropriate pharmacologic prophylaxis dosing in the obese may result in subtherapeutic levels. Increased procedural complications exist in this patient population, and limited intravenous access may increase the duration of central access, which can lead to thrombosis.

Diagnosis of VTE may also be compromised. Studies have shown that clinical signs of a DVT are often absent. Entities involved in critical illness such as peripheral edema–decreased sensorium, surgical dressing, and adiposity further impair clinical signs of DVT (41).

The best regimen for thromboprophylaxis in this high-risk group is not single armed. The risk of bleeding should be balanced with the risk of thrombosis. In patients with low risk of bleeding, chemoprophylaxis should be used in conjunction with mechanical prophylactic devices such as intermittent pneumatic compression boots. If the bleeding risk is high, mechanical prophylactic devices should be used until chemoprophylaxis can be instituted. Prophylactic inferior vena cava filters can be considered, but not recommended for primary prophylaxis. Unfractionated or low–molecular-weight heparins are both viable options though precise dosing regimens and duration of dosage have emerged largely from uncontrolled trials. There are reports in the bariatric literature that 40 mg of enoxaparin every 12 hours may provide better thromboprophylaxis than 30 mg every 12 hours. Weight-based dosing of 0.5 mg/kg with weights over 150 kg following anti-factor Xa levels after the third dose with the goal of 0.2 to 0.5 IU/mL is suggested by many authors (42).


Venous access is difficult in this population. Peripheral venous access is often limited. Use of ultrasound can be very helpful in gaining peripheral access in this population. When central access is needed peripherally inserted central catheters (PICCs) should be considered as central catheters may remain in place longer in the obese patient than nonobese patients and may cause increased risk of infection (43). Ultrasound guidance has been particularly helpful in the placement of central venous catheters in the morbidly obese patient. Ultrasound guidance can overcome the limitation of altered surface anatomic landmarks in the obese patient. Many authors suggest internal jugular over other sites due to the ability to visualize the vessels easier with ultrasound guidance in this population. Arterial access is recommended as noninvasive blood pressure cuffs can give inaccurate measurements in this patient population. When accessing a vessel in this population, longer equipment may be needed. Catheters placed in left internal jugular may not be of adequate length to reach the distal superior vena cava. Greater care should be taken when securing the catheter. Excess adipose tissue can shift when the patient is in an upright position thereby pulling the distal catheter out of the vessel without evidence of movement on the skin surface.

When using a noninvasive blood pressure cuff, the bladder size should be at least 80% of the arm circumference in length with a width of at least half of the arm length.


Obese critically ill patient may have increased protein catabolism. In addition, many obese patients are paradoxically malnourished. Early enteral feedings should be instituted if possible. Estimation of nutritional needs done by indirect calorimetry if available or by resting energy expenditure equations. There is some literature that suggests hypocaloric feeding while maintaining high protein intake in the obese critically ill patient to avoid overfeeding. General goals of nutrition are 20 to 25 kcal/kg of ideal body weight per day with 2.0 g/kg ideal body weight of protein. Obese patients have also been found to have significant micronutrient deficiencies. These deficiencies of vitamin D, thiamine, copper, zinc, selenium among others can be made worse by bariatric surgical procedures and should be supplemented when low (44–46).


There is no consensus whether obesity confers a survival advantage or disadvantage in critical illness. This disparity may reflect the difficulty in defining obesity only based on a measure of weight and not the complex tissue and system effect of adiposity. Obese patients present the entire critical care team with obstacles to overcome. From acute illness and resuscitation to mobilization and rehabilitation; the morbidly obese critically ill patient requires an understanding of the pathophysiology at a cellular, tissue, and system level.

Key Points

  • Obesity is a worldwide epidemic in which the morbidly obese is rapidly increasing.
  • In the morbidly obese, adipose tissue is immunologically active and through a multitude of inflammatory pathways causes pathology on cellular, tissue, and system levels.
  • Changes to the cardiopulmonary system, lead to little reserve during critical illness. Obese patients have increased blood volume.
  • Increase in body mass leads to increase oxygen demand, and results in chronic stress on myocardium coupled with increase in arterial resistance can lead to left ventricular systolic and diastolic dysfunction.
  • FRC is chronically decreased in the morbidly obese leading to V/Q mismatch and hypoxia. This coupled with decreased excursion of diaphragms and decreased chest wall compliance can lead to rapid desaturation during critical illness and intubation.
  • Anatomical alterations from fat deposits of the upper airway and increased resistance from narrowed trachea and bronchioles can be additive, making the morbidly obese patient a “difficulty airway.”
  • Intensivists underestimate the amount of peep to recruit collapsed alveoli in the ventilated morbidly obese. Levels of at least 10 cm H2O should be a started point.
  • Consideration of extubating to NIPPV even in recent thoracic and bowel surgery should be strongly considered. There has been no evidence that NIPPV in postoperative patient disrupts anastomosis except for possibly the pharyngeal and oral surgeries.
  • Drug dosing in the morbidly obese is complex and maybe unique in each patient. Underdosing antibiotics and anticoagulation has been shown to be as serious a problem as overdosing. Expert consultation with critical care pharmacist is imparitive.
  • Many morbidly obese patients are malnourish both macro and micronutrients. Adequate protein should be given.
  • Morbidly obese patients should not be ridiculed, or disparaged.
  • Equipment should be made available to morbidly obese patient that can safely handle extreme weight safely.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 26, 2020 | Posted by in CRITICAL CARE | Comments Off on The Morbidly Obese Patient in the Critical Care Unit

Full access? Get Clinical Tree

Get Clinical Tree app for offline access